You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RQ-PCR

Showing 26 - 50 of 1,845
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory Trial in Worldwide (Radotinib HCl)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Radotinib HCl
  • Uijeongbu-si, Gyeonggi-do, Korea, Republic of
  • +17 more
Jan 3, 2022

Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt

Completed
  • Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
  • Cairo, Egypt
    National Cancer Institute (NCI)
Feb 22, 2021

Generic Imatinib Compared to Glivec® in Real-Life Management of

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Cairo, Egypt
  • +1 more
Mar 16, 2022

Diabetes, Type 2 Trial in Baton Rouge (High fat meal, Low fat meal)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • High fat meal
  • Low fat meal
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Aug 21, 2021

Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

Active, not recruiting
  • Esophageal Cancer
  • follow up
  • Guangzhou, Guangdong, China
    Jianhua Fu
Sep 24, 2023

Leukemia, Myeloid, Chronic-Phase Trial in Bordeaux (Imatinib Mesylate 600 MG Oral Tablet, Imatinib Mesylate 400 MG Oral Tablet,

Terminated
Has Results
  • Leukemia, Myeloid, Chronic-Phase
  • Imatinib Mesylate 600 MG Oral Tablet
  • +2 more
  • Bordeaux, Aquitaine, France
    Institut Bergonié
Dec 30, 2020

Aging Trial (Time Restricted Eating Intervention)

Not yet recruiting
  • Aging
  • Time Restricted Eating Intervention
  • (no location specified)
Jul 29, 2022

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, China
      Peking University People's Hospital(北京大学人民医院)
    Jan 3, 2022

    Leukemia, Chronic Myeloid Trial in Campinas (Pioglitazone, imatinib discontinuation)

    Active, not recruiting
    • Leukemia, Chronic Myeloid
    • Campinas, SP, Brazil
      Centro de Hematologia e Hemoterapia - Universidade Estadual de C
    Nov 2, 2020

    Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

    Completed
    Has Results
    • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
    • Loma Linda, California
    • +35 more
    Mar 25, 2021

    ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

    Recruiting
    • Breast Cancer Female
    • +4 more
      • Ho Chi Minh City, Vietnam
      • +1 more
      Oct 16, 2023

      Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

      Active, not recruiting
      Has Results
      • Chronic Myelogenous Leukemia
      • Chicago, Illinois
      • +87 more
      Jan 20, 2023

      Multiplex PCR Pneumonia Panel in ICU Severe Pneumonia.

      Not yet recruiting
      • Community-acquired Pneumonia
      • +2 more
      • Multiplex respiratory PCR
      • Marrakesh, Marrakesh Tensift El Haouz, Morocco
        Avicenna Military Hospital
      Jan 30, 2023

      Breast Cancer Patients

      Completed
      • Neoadjuvant Chemotherapy
      • Neoadjuvant therapy
      • Istanbul, Turkey
        AcıbademAH
      Nov 21, 2023

      Rectal Cancer Trial in Taipei (Surgery)

      Recruiting
      • Rectal Cancer
      • Surgery
      • Taipei, Taiwan
        Jin-Tung LIANG
      Jul 27, 2023

      t Pathologic Complete Response Observed in HER2 Positive Breast

      Completed
      • HER2+ Breast Cancer
      • Rawalpindi, Punjab, Pakistan
        Rawalpindi Medical University
      Jun 26, 2023

      Gastric/Colorectal Cancers

      Not yet recruiting
      • Gastric Cancer
      • Colo-rectal Cancer
      • quantitative Real-time PCR
      • (no location specified)
      Nov 27, 2023

      Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast

      Recruiting
      • Breast Cancer
      • Response monitoring
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Feb 24, 2023

      COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

      Completed
      • COVID-19 Respiratory Infection
        • Geneva, Switzerland
        • +2 more
        Sep 25, 2023

        Role of Multiplex PCR in CAP

        Not yet recruiting
        • Community-acquired Pneumonia
        • MultiplexPCR
        • (no location specified)
        Oct 20, 2023

        Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • Atezolizumab + RP1
        • Paris, France
          Institut Curie
        Oct 2, 2023

        Breast Cancer Trial in Gaia (Combined Aerobic and Resistance Exercise)

        Not yet recruiting
        • Breast Cancer
        • Combined Aerobic and Resistance Exercise
        • Gaia, Porto, Portugal
          Centro Hospitalar Vila Nova Gaia e Espinho
        Jul 27, 2023

        NSCLC, EGF-R Positive NSCLC Trial in Shenyang (Icotinib, Cisplatin, Carboplatin)

        Not yet recruiting
        • NSCLC
        • EGF-R Positive Non-Small Cell Lung Cancer
        • Shenyang, Liaoning, China
          Liaoning Cancer Hospital & Institute
        Nov 28, 2021

        COVID-19 Trial in Miami, Knoxville, Memphis (RT-PCR Test, Real-time PCR Test)

        Recruiting
        • COVID-19
        • RT-PCR Test
        • Real-time PCR Test
        • Miami, Florida
        • +2 more
        Dec 20, 2022